Drug Shortage Report for TIAZAC XC
| Report ID | 263524 |
| Drug Identification Number | 02256746 |
| Brand name | TIAZAC XC |
| Common or Proper name | TIAZAC XC |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
| Strength(s) | 180MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 90's |
| ATC code | C08DB |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2025-07-22 |
| Estimated end date | 2025-10-06 |
| Actual end date | 2025-10-06 |
| Shortage status | Resolved |
| Updated date | 2025-10-08 |
| Company comments | Raw material/API - Out of Specification |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2025-10-08 | French | Compare |
| v7 | 2025-10-08 | English | Compare |
| v6 | 2025-10-02 | French | Compare |
| v5 | 2025-10-02 | English | Compare |
| v4 | 2025-09-10 | French | Compare |
| v3 | 2025-09-10 | English | Compare |
| v2 | 2025-07-25 | French | Compare |
| v1 | 2025-07-25 | English | Compare |
Showing 1 to 8 of 8